Federal Official Gazette
ANS OPERATIONAL RESOLUTION No. 3,082, OF DECEMBER 19, 2025
Provides for the granting of special portability of waiting periods to the beneficiaries of the operator POLIMÉDICA SAÚDE SOCIEDADE SIMPLES LTDA.
ANS OPERATIONAL RESOLUTION No. 3,083, OF DECEMBER 19, 2025
Provides for the order to divest the portfolio of the operator SAÚDE BRASIL ASSISTÊNCIA MÉDICA LTDA
ANS news
ANS receives Gold and Silver seals for Regulatory Best Practices
The National Supplementary Health Agency (ANS) received the Gold and Silver seals in the 3rd Edition of the Regulatory Best Practices Seal, an initiative of the Ministry of Development, Industry, Trade and Services (MDIC) that recognizes normative acts drafted on the basis of regulatory quality criteria. ANS receives Gold and Silver seals for Regulatory Best Practices — National Supplementary Health Agency
ANS expands treatments available in Rol A
The Board of Directors of the National Supplementary Health Agency (ANS) approved, at a meeting on Dec 19, an update to the List of Health Procedures and Events (Rol) with new guidelines for use (DUTs) for two technologies, namely:
Abemaciclib, a drug to treat patients with early breast cancer, through the update of DUT 64 in Annex II of Normative Resolution No. 465/2021, relating to the procedure Oral Antineoplastic Therapy for Cancer Treatment (with guideline for use), with the following indication: adjuvant treatment of adult patients with early breast cancer at high risk of recurrence, hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative and node positive; and
Romosozumab, a drug intended for women with postmenopausal osteoporosis, through the update of DUT 65.15, relating to the procedure Intravenous, Intramuscular or Subcutaneous Immunobiological Therapy (with guideline for use). ANS expands treatments available in the Rol — National Supplementary Health Agency
ANS approves new enforcement model for supplementary health
The National Supplementary Health Agency (ANS) approved, at an extraordinary meeting of the Board of Directors (DICOL) held on Friday, Dec 19, a rule establishing the New Enforcement Model for the Supplementary Health Sector. The initiative represents an advance in modernizing the Agency’s enforcement activity, with a greater focus on preventing conflicts, improving the beneficiary experience and increasing incentives for the adoption of good practices by health plan operators and benefits administrators. Among the main changes brought by the new model are: individual analyses of complaints by sampling, carried out on the basis of criteria previously defined and approved by the Board of Directors; a redesign of planned and strategic enforcement actions; and adjustments to types of infractions and to the amount of monetary fines; ANS approves new enforcement model for supplementary health — National Supplementary Health Agency
Open public consultations
- CP 164. Public Consultation (CP) No. 164 aims to receive contributions on the preliminary recommendations relating to health technologies proposed internally by ANS, originating from the incorporations of technologies into the Unified Health System (SUS) on the recommendation of the Comissão Nacional de Incorporação de Tecnologias no SUS (CONITEC), carried out in the period from May 2, 2019 to Sep 2, 2021. These proposed updates to the Rol are being presented in accordance with Art. 38 of RN No. 555 of 2022. The consultation also submits to public participation the Preliminary Report resulting from the 43rd technical meeting of the Comissão de Atualização do Rol de Procedimentos e Eventos em Saúde Suplementar (COSAÚDE), in compliance with Art. 10, § 11, item III, of Law No. 9,656/1998, as added by Law No. 14,307 of 2022, and with Art. 26 of RN No. 555 of 2022. Deadline: Dec 23, 2025.
- CP 165. Aims to receive contributions on the proposed Normative Resolution on the transfer of portfolios of private health care plans between private health care plan operators. Deadline: Jan 23, 2026.
- CP 166. Aims to receive contributions on the preliminary recommendation of non-incorporation for the technologies contained in UATs No. 178, 179 and 182. Deadline: Dec 30, 2025.
Scheduled public hearings
There are no public hearings scheduled.
Open public calls for input
- A Public Call for Input (TPS) is open from December 16, 2025 to January 31, 2026, intended to receive suggestions on the priority supplementary health topics that will inform the composition of the 2026-2028 Regulatory Agenda of the National Supplementary Health Agency (ANS).
Open public calls
No updates.
Other news
Rise in cancer among young people explains higher cost of private healthcare in the country
According to a survey, medical inflation is expected to exceed 11% in 2025; the study takes into account factors such as health plan and drug prices
The future of digital health in the SUS is a political problem, not just a technical one
In short, these are the points where the substitute text presented in December 2025 errs. There are some dimensions that need to be revised and that seem to us non-negotiable:
(1) Never before contemplated in the SUS, the exploitation of business models and services based on data processed by the National Health Data Network (RNDS) is now provided for. This scenario opens a gap for a possible link between the national health interoperability infrastructure and the data monetization agenda under study by the public administration. Even if it does not involve the sale of data in raw format, it amounts to opening the door to other forms of participation in the circuits of capital, for example, via assetization.
(2) As if the absence of any mention of the National Health Council (CNS) as a participatory body were not enough, the text provides for a RNDS governance body that is given a series of legal prerogatives and is prominently composed of the private sector (hospitals and clinics, health plan operators, laboratories and diagnostic centers, digital health platforms and health information systems). The sector — which is constitutionally recognized, the more legalistic would say — should not occupy structuring roles in public health policy. This body needs to be eliminated.(3) The use of data must be guaranteed only for scientific and technological research, expressly limited to non-profit bodies, through an evaluation process subject to social oversight and to research ethics rules – recently relaxed by the abolition of the Comissão Nacional de Ética em Pesquisa com Seres Humanos – Conep (which raises additional concerns in the case of this Bill).
The future of digital health in the SUS is a political problem, not just a technical one – Viomundo
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.